This is a report from the National Academy of Medicine that describes the impact of the opioid crisis and promising approaches for five specific subpopulations: justice-involved populations, rural populations, veterans, adolescents and young adults, and persons who inject drugs.
Treatment Resources
- Educational
- Medications for Opioid Use Disorder
- Community Coalitions
- Community Health Officials
- Criminal Justice
- Harm Reduction Specialists
- Policymakers
This is an academic article from an expert in adolescent treatment of opioid use disorder that discusses the results of a previous trial of youth and young adults randomized to either extended-release naltrexone or buprenorphine. Outcomes were worse in youth, and this commentary discusses the problems of the treatment system for this population.
- Early Intervention
- Medications for Opioid Use Disorder
- Addiction Treatment Providers
- Health Insurers
- Hospitals
- Medical
CHERISH is a research collaborative that informs real-world substance use interventions through health economic research. The website contains a range of resources including economic evaluations for various interventions and budget tools, including a tool for implementing medications for opioid use disorder in jails and prisons.
- Medications for Opioid Use Disorder
- Health Insurers
- Policymakers
This is a report from Children and Family Futures that defines and provides examples of collaborative practice in each of the ten system linkage elements, focused in the child welfare, substance use treatment, and juvenile court dependency systems. State and community collaborative groups can use this information to guide their own efforts to implement collaborative practice in their own communities.
- Early Intervention
- Educational
- Family Support
- Community Coalitions
- Community Health Officials
- Criminal Justice
- Policymakers
This is an editorial in an academic journal about the impact of the coronavirus pandemic on different aspects of the opioid use disorder treatment system, including opioid treatment providers, buprenorphine prescribing, bridge clinics, telemedicine, and delivery of harm reduction.
- COVID / Coronavirus related
This is an academic paper that provides a systematic review of existing research that has empirically evaluated interventions designed to reduce stigma related to substance use disorders. A range of interventions demonstrate promise for achieving meaningful improvements in self-, social-, and structural-level stigma.
- Educational
- Addiction Treatment Providers
- Advocates / Peers
- Community Coalitions
- Community Health Officials
- Criminal Justice
- Employers
- First Responders
- Harm Reduction Specialists
- Health Insurers
- Hospitals
- Law Enforcement
- Medical
- Pharmacies
- Policymakers
This toolkit provides an overview of essential information necessary for understanding mental health and substance use disorder parity and how to implement and comply with federal parity laws. It serves as a reference document for state insurance regulators and behavioral health staff to develop a better understanding of parity and to take action to improve compliance with parity laws.
- Educational
- Health Insurers
- Policymakers
This is a written testimony from 2017 presented to Congress by experts in the Department of Health and Human Services outlining the steps the department has taken to advance the goals of the Opioid Strategy. This document presents how leaders at SAMHSA, CDC, NIH, and FDA bring unique expertise and capabilities that enable HHS to take a comprehensive, complementary, and flexible approach to the opioid crisis.
- Cautious Opioid Prescribing
- Medications for Opioid Use Disorder
- Overdose prevention
- Addiction Treatment Providers
- Community Coalitions
- Community Health Officials
- Harm Reduction Specialists
- Medical
- Policymakers
This is a website where you can download a report from Shatterproof that reviews data from states that suffered the highest number of fentanyl overdose deaths from 2011 through 2017. Based on reviewing this data, the report identifies a number of promising state initiatives that are already in place and having a positive effect on curbing overdose deaths. It also recommends several new strategies that states should adopt in order to save the most lives.
- Educational
- Medications for Opioid Use Disorder
- Overdose prevention
- Community Coalitions
- Community Health Officials
- Criminal Justice
- Medical
- Policymakers
This working paper (authors Brill and Ganz) from the American Enterprise Institute provides an estimation of the economic cost of the opioid crisis to each state and each county.
- Educational
- Community Coalitions
- Criminal Justice
- Health Insurers
- Hospitals
- Policymakers
This paper outlines the relationship between stigma and opioid use disorder and explains how this has impacted treatment provision and harm reduction. The authors used a framework to identify sources of opioid related stigma on the macro, meso, and micro level. The authors also provide potential policy suggestions for how to reduce these impacts of stigma.
- Educational
- Overdose prevention
- Advocates / Peers
- Community Health Officials
- Policymakers
This webinar was presented to address the problem of opioid addiction in the rural workforce, with 45% of rural adults saying they have been impacted by the opioid epidemic, and 74% of farmers and farmworkers saying they have been directly affected. It describes resources, promising practices, and grant opportunities available to rural workforce systems, employers, and business on supporting recovery efforts in the workplace.
- Employers